Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Gutterman (Milwaukee, Wi, United States of America). Cardiovascular disease and complex OSA. Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 Cardiovascular morbidity in OSA Source: Annual Congress 2003 - PG4 - Obstructive sleep apnoea - current pathophysiological, clinical and therapeutic concepts Year: 2003 Cardiovascular complications of mild OSA Source: International Congress 2017 – Sleep and Breathing Year: 2017 Cardiovascular complications of mild OSA Source: ERS Conference Year: 2015 Cardiovascular complications in mild OSA Source: Sleep and Breathing Conference 2017 Year: 2017 Cardiovascular diseases and COVID-19 Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Assessment of cardiovascular comorbidity Source: Eur Respir Mon 2013; 59: 28-49 Year: 2013 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Obstructive sleep apnoea and increased inflammatory activity in non-obese patients with coronary artery disease in the RICCADSA trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015